Open original FDA record ↗Recall record
- FDA identifier
- Z-0102-2019
- Company in FDA record
- OriGen Biomedical, Inc.
- FDA record creation date
- Oct 12, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The catheter failed the endotoxin testing.
Source facts
- Action
- On 08/21/18, the firm emailed a recall notice to customers informing them of a nationwide recall of RDLC ECMO catheters. Customers were advised to return affected product to the firm. Customers with additional questions were advised to call 1-800-233-9014 or 1-512-474-7278. The firm also sent customers Technical Bulletin (TB) 1411 - Revision Feb 2018, Subject: Radiopacity of the Reinforced Dual Lumen Catheter (RDLC), Date: July 2015, and an Acknowledgment Receipt form to complete and return. On 09/12/18, and 09/20/18, the firm sent two additional recall notices, which included additional affected lot numbers that were not the subject of the current removal.
- Initiated
- 2018-08-21
- Root cause
- Release of Material/Component prior to receiving test results
- Terminated
- 2021-10-05
- Distribution
- US Nationwide in the states of NY, AR, MO, NC, GA, LA, CO, AL, MA, CA, MI, TX, OH, MD, FL, TN, SC, OR, AZ, UT, RI, SD, PA, NM, CT. Foreign (OUS): United Arab Emirates, Kingdom of Saudi Arabia, New Zealand, Thailand
- Recall number
- Z-0102-2019
- Recall status
- Terminated
- CDRH record ID
- 167443
- FDA record created
- 2018-10-12
- Recall event number
- 81098